Automate Your Wheel Strategy on SYK
With Tiblio's Option Bot, you can configure your own wheel strategy including SYK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SYK
- Rev/Share 62.3182
- Book/Share 55.4448
- PB 7.0284
- Debt/Equity 0.8083
- CurrentRatio 1.7842
- ROIC 0.1151
- MktCap 148981214830.0
- FreeCF/Share 10.5285
- PFCF 37.0232
- PE 51.0416
- Debt/Assets 0.3697
- DivYield 0.0085
- ROE 0.1408
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | SYK | Citigroup | -- | Buy | -- | $450 | Feb. 26, 2025 |
| Initiation | SYK | Wolfe Research | -- | Outperform | -- | $405 | Sept. 10, 2024 |
News
Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day
SYK
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headquarters, New York, New York.
Read More
About Stryker Corporation (SYK)
- IPO Date 1980-03-17
- Website https://www.stryker.com
- Industry Medical - Devices
- CEO Kevin A. Lobo
- Employees 53000
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.